United States · FDA National Drug Code directory
DALFAMPRIDINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-863_8a071f78-8849-495d-ad29-832d5f250a19
- Product NDC
- 65862-863
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- DALFAMPRIDINE
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180625
- Source listing expiry
- 20261231
Source-listed ingredients
- DALFAMPRIDINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-863-01) · 65862-863-01
- 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-863-05) · 65862-863-05
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-863-60) · 65862-863-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →